References
- Bulmer G.S., Sans M.D. Cryptococcus neoformans. II. Phagocytosis by human leucocytes. Journal of Bacteriology 1967; 94: 1480–1483
- Bulmer G.S., Sans M.D. Cryptococcus neoformans. III. Inhibition of phagocytosis. Journal of Bacteriology 1968; 95: 5–8
- Bulmer G.S., Sans M.D., Gunn C.M. Cryptococcus neoformans. I. Non-encapsulated mutants. Journal of Bacteriology 1967; 94: 1475–1479
- Bulmer G.S., Tacker J.R. Phagocytosis of Cryptococcus neoformans by alveolar macrophages. Infection & Immunity 1974; 11: 73–79
- Farhi F., Bulmer G.S., Tacker J.R. Cryptococcus neoformans. IV. The not-so-encapsulated yeast. Infection and Immunity 1970; 1: 526–531
- Ishaq C.M., Bulmer G.S., Felton F.G. An evaluation of various environmental factors affecting the propagation of Cryptococcus neoformans. Mycopathologia et Mycologia Applicata 1968; 35: 81–90
- Littman M.L., Walker J.E. Cryptococcosis: Current status. American Journal of Medicine 1968; 45: 922–922
- Littman M.L., Zimmerman L.E. Cryptococcosis-Torulosis or European Blastomycosis. Grune and Stratton, New York 1956
- Neilson J.B., Bulmer G.S. The infectious particles of Cryptococcus neoformans. Abstracts of the American Society for Microbiology 1975, F45
- Staib F. New concepts in the occurrence and identification of Cryptococcus neoformans. Mycopathologia et Mycologia Applicata 1963; 19: 143–145
- Tacker J.R., Farhi F., Bulmer G.S. Intracellular fate of Cryptococcus neoformans. Infection and Immunity 1972; 6: 162–167
- Takos M.J. Experimental cryptococcosis produced by the ingestion of virulent organisms. New England Journal of Medicine 1956; 254: 598–601
- Vickers R.M., McElligot J.J., Rihs J.D., Postic B. Medium containing trypan blue and antibiotics for the detection of Cryptococcus neoformans in clinical samples. Applied Microbiology 1974; 27: 38–42